The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will ...

A new class of weight-loss drugs touted as a revolutionary breakthrough in obesity management have received global attention, ...

For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...

We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

The 77-year-old music legend has revealed that he can no longer see out of his right eye after suffering an eye infection ...

These 3 iPad Pro Features Should Come to the iPhone ...